Evidence map›Paper›PMID 37171385›Full record

ArticleOncotarget2023

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling.

Stephan J Matissek, Mona Karbalivand, Weiguo Han, Ava Boutilier, Estefania Yzar-Garcia, Laura L Kehoe, Devin Storm Gardner, Adam Hage, Krista Fleck, Vicki Jeffers and 2 more

Open access · diamondAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Stephan J MatissekDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Mona KarbalivandDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Weiguo HanDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Ava BoutilierDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Estefania Yzar-GarciaDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Laura L KehoeDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Devin Storm GardnerDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Adam HageDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Krista FleckDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Vicki JeffersDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Ricardo RajsbaumDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Sherine F ElsawaDepartment of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
University of New Hampshire · USThe University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37171385
PMCPMC10178449
OpenAlexW4376224768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.